Invasive Group G Streptococcal Infection Complicated by Posterior Reversible Encephalopathy Syndrome: A Case Report.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
28 Nov 2023
Historique:
medline: 30 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

BACKGROUND Group G streptococcus (GGS) infection is reported to have invasive pathogenicity similar to that of group A streptococcus (GAS) infection, causing a strong systemic inflammatory response with bacteremia and various complications. Herein, we report a case of posterior reversible encephalopathy syndrome (PRES) as a rare complication of a GGS infection. CASE REPORT An 89-year-old Japanese man presented to our hospital with gastrointestinal bleeding and shoulder pain. Close examination revealed a refractory duodenal ulcer (DU) with disseminated intravascular coagulation and soft tissue infection of the right arm, which was found to be caused by GGS. A hemorrhagic tendency due to disseminated intravascular coagulation made it difficult to achieve hemostasis, leading to repeated blood transfusions. Although remission of both the DU and infection was achieved with treatment, impairment of swallowing function and vision subsequently appeared. Magnetic resonance imaging revealed hyperintense lesions with elevated apparent diffusion coefficient (ADC) values on T2-weighted imaging (T2WI), fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI). The patient was diagnosed with PRES, which did not improve even after discharge on day 118. CONCLUSIONS GGS infection developed with refractory duodenal ulcer bleeding, resulting in PRES with irreversible sequelae. The occurrence of PRES, which may be a rare complication of GGS infection, should be considered when central nervous system manifestations are observed in case of invasive streptococcal infection with a systemic inflammatory response.

Identifiants

pubmed: 38015823
pii: 942206
doi: 10.12659/AJCR.942206
pmc: PMC10697558
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e942206

Références

Neurol Sci. 2019 May;40(5):915-922
pubmed: 30604335
J Intensive Care. 2014 Feb 20;2(1):15
pubmed: 25520831
Arch Dermatol. 2009 Jul;145(7):846-7
pubmed: 19620577
J Biomol Struct Dyn. 2019 May;37(8):1944-1955
pubmed: 29726798
AJNR Am J Neuroradiol. 2008 Jun;29(6):1043-9
pubmed: 18403560
J Coll Physicians Surg Pak. 2018 Jan;28(1):80-81
pubmed: 29290203
J Infect Chemother. 2011 Feb;17(1):1-10
pubmed: 20607346
J Neurol Neurosurg Psychiatry. 1984 Nov;47(11):1223-31
pubmed: 6094735
J Intensive Care. 2014 Mar 06;2(1):20
pubmed: 25520834
Biocontrol Sci. 2018;23(2):77-80
pubmed: 29910212
Clin Case Rep. 2022 Jan 11;10(1):e05286
pubmed: 35035968
Infect Immun. 1985 Jan;47(1):52-60
pubmed: 3880730
Gastroenterology. 2018 Sep;155(3):674-686.e6
pubmed: 29803838
Brain Nerve. 2017 Feb;69(2):129-141
pubmed: 28202821
AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2179-90
pubmed: 17110690
AJNR Am J Neuroradiol. 2000 Aug;21(7):1199-206
pubmed: 10954269
Lancet Neurol. 2015 Sep;14(9):914-925
pubmed: 26184985
Crit Care Med. 2004 Jul;32(7):1535-41
pubmed: 15241098
N Engl J Med. 2017 Dec 7;377(23):2253-2265
pubmed: 29211672
Emerg Infect Dis. 2017 Jan;23(1):127-129
pubmed: 27983491
Int J Syst Bacteriol. 1996 Jul;46(3):774-81
pubmed: 8782689
AJR Am J Roentgenol. 1992 Aug;159(2):379-83
pubmed: 1632361
World J Surg. 2018 Jan;42(1):82-87
pubmed: 28762168
Clin Microbiol Infect. 2010 Aug;16(8):1097-103
pubmed: 19732082
Rinsho Shinkeigaku. 2012;52(3):147-51
pubmed: 22453037
Infect Dis Clin North Am. 1999 Jun;13(2):387-96, ix
pubmed: 10340173
Lancet. 2002 Jan 12;359(9301):124-9
pubmed: 11809255
BMC Neurol. 2018 Nov 12;18(1):190
pubmed: 30419835
N Engl J Med. 1996 Feb 22;334(8):494-500
pubmed: 8559202

Auteurs

Hironori Nakamura (H)

Department of Internal Medicine, Gifu-Seino Medical Center, Ibi Kosei Hospital, Ibigawa, Gifu, Japan.

Seiji Adachi (S)

Department of Internal Medicine, Gifu-Seino Medical Center, Ibi Kosei Hospital, Ibigawa, Gifu, Japan.

Yukari Uno (Y)

Department of Internal Medicine, Gifu-Seino Medical Center, Ibi Kosei Hospital, Ibigawa, Gifu, Japan.
First Department of Internal Medicine, Gifu University Graduate School of Medicine, Ibigawa, Gifu, Japan.

Masatoshi Mabuchi (M)

Department of Internal Medicine, Gifu-Seino Medical Center, Ibi Kosei Hospital, Ibigawa, Gifu, Japan.

Makoto Shimazaki (M)

Department of Internal Medicine, Gifu-Seino Medical Center, Ibi Kosei Hospital, Ibigawa, Gifu, Japan.

Shinji Nishiwaki (S)

Department of Internal Medicine, Gifu-Seino Medical Center, Ibi Kosei Hospital, Ibigawa, Gifu, Japan.

Masahito Shimizu (M)

First Department of Internal Medicine, Gifu University Graduate School of Medicine, Ibigawa, Gifu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH